GV joins $50 million round in Rome Therapeutics to research ‘junk DNA’ for cancer therapies
Rome Therapeutics, a biotechnology startup that’s using machine learning (ML) to explore the human genome and develop new treatments for…
Rome Therapeutics, a biotechnology startup that’s using machine learning (ML) to explore the human genome and develop new treatments for…